Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/15/2025
Chengdu MedGenCell Secures Strategic Investment for Cell Therapy Innov...
1/15/2025
Longen Therapeutics Secures Over CNY 100M in Pre-A Financing
1/15/2025
Ucello Wins FDA IND Approval for Pioneering Allogeneic CAR-T Therapy
1/15/2025
Luye Pharma Advances CNS Pipeline with Phase II Trial for LY03015 in C...
1/15/2025
U.S. Tightens Export Controls on Biotech Equipment Over AI and Securit...
1/14/2025
Ikena and Inmagene Biopharma Agree to Merger Deal
1/14/2025
CR Pharma Partners with NAMI to Explore Palbociclib for Alzheimer's Tr...
1/14/2025
Biophytis Enters Exclusive Negotiations with a Chinese Pharma Firm to ...
1/14/2025
ImmuneOnco Begins Trial of Instil's NSCLC Drug in China
1/14/2025
NHSA Hosts Roundtable on Supporting Innovative Drug Development
1/13/2025
Vertex, Zai Lab Enter Asian Licensing Pact for Povetacicept
1/13/2025
AbbVie and Simcere Zaiming Forge Partnership for a Novel Trispecific A...
1/13/2025
Hengruiand Kailera Report Positive Data from Phase 2 Obesity Trial of ...
1/13/2025
J&J's Balversa (Erdafitinib) Gains NMPA Approval for Advanced Urotheli...
1/13/2025
Livzon Group Discontinues LZM009 PD-1 Program Amid Strategic Rethink ...
1/13/2025
Regor Releases Phase 2a Topline Results for GLP-1 RGT-075
1/13/2025
Akeso Launches Phase 3 Trial for Ivonescimab (AK112)
1/13/2025
Okejian Bio Secures CNY 100M+ in Series A Financing to Advance Innova...
1/13/2025
CirCode Receives NMPA IND Approval for HM2002 Injection
1/13/2025
Gentize Biopharma Secures ~CNY 100M in Pre-A Financing to Advance Vacc...
1/13/2025
China's Dealmaking Slows as India and Other APAC Markets Emerge as Key...
1/13/2025
NMPA Announces Package Insert Revision of Human Albumin Injection
1/13/2025
Review of New Drugs Approved in China in 2024
1/12/2025
Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Unc...
1/12/2025
Imunopharm Secures Series E Financing to Support IM19 Commercializatio...
1/12/2025
CMS Licensed Dimentia Drug ZUNVEYL from Alpha Cognition
1/12/2025
WuXi Biologics Announces Agreement with Candid Therapeutics on Trispec...
1/12/2025
New Biotech Startups with Strong China Ties and Investor Backing Launc...
1/12/2025
Keymed Biosciences and Timberlyne Therapeutics Forge Exclusive Licensi...
1/12/2025
HealZen and SIMM Announce Global Deal with J&J to Advance BTK Degrader
Page:
29
/
775
Total number of articles:
23233
:
[First]
[<<]
[27]
[28]
[29]
[30]
[31]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit